Pallas Capital Advisors LLC Acquires Shares of 40,511 Axsome Therapeutics, Inc. $AXSMMarket Beat·1 day ago, 05:08 AMAXSM+1.16%
Here’s How Much You Would Have Made Owning Axsome Therapeutics Stock In The Last 5 Yearsbenzinga_article·2 days ago, 03:15 PMAXSM+1.16%
If You Invested $100 In Axsome Therapeutics Stock 10 Years Ago, You Would Have This Much Todaybenzinga_article·Aug 13 at 06:00 PMAXSM+1.16%
Axsome Therapeutics Analysts Increase Their Forecasts Following Q2 Resultsbenzinga_article·Aug 11 at 09:30 AMAXSM+1.16%
Target To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Tuesdaybenzinga_article·Aug 11 at 06:59 AMBBY+2.22%AXSM+1.16%
Axsome Q2 FY26 net loss widens to $51.3 million; net product revenue climbs 46% to $218.4 million year over yearPUBT·Aug 10 at 06:08 AMAXSM+1.16%
Axsome Therapeutics shares Q2 2026 financial results and business update.Unusual Whales·Aug 10 at 06:08 AMAXSM+1.16%
AXSM: 46% revenue growth in 2Q 2026 driven by AUVELITY's Alzheimer's launch and pipeline progressQuartr·Aug 10 at 06:03 AMAXSM+1.16%
These Are the Stocks Reporting Earnings Today – August 10, 2026Tip Ranks·Aug 10 at 03:00 AMQUBT-1.17%SPG+1.16%
Axsome CEO Herriot Tabuteau disposes of USD 10.54 million in common sharesPUBT·Aug 7 at 06:00 PMAXSM+1.16%
Axsome Therapeutics (AXSM) Stock Looks Near Fair Value Despite Premium Sales PricingSimplywall·Aug 6 at 10:58 PMAXSM+1.16%
Axsome Therapeutics (NASDAQ:AXSM) Stock Price Down 4% After Analyst DowngradeMarket Beat·Aug 3 at 11:20 AMAXSM+1.16%GS-C+0.88%
Axsome Therapeutics, Inc. $AXSM Shares Sold by Tri Locum Partners LPMarket Beat·Jul 30 at 05:32 AMAXSM+1.16%
